Literature DB >> 10844101

Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat.

A V Vergoni1, A Ottani, A R Botticelli, D Zaffe, L Guano, A Loche, S Genedani, G L Gessa, A Bertolini.   

Abstract

The effect of gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia was studied in the four vessel occlusion rat model. In saline-treated animals, 30 min ischemia caused a massive loss of neurons in the hippocampal CA1 subfield (normal neurons: 14%, 5%, 23% and 30% on the 3rd, 10th, 15th and 65th day after ischemia, respectively). gamma-Hydroxybutyrate - 300 mg/kg intraperitoneally (i.p.) 30 min before or 10 min after arteries occlusion, followed by 100 mg/kg i.p. twice daily for the following 10 days - afforded a highly significant protection (normal neurons on the 3rd, 10th, 15th and 65th day after ischemia: 88% and 91%, 80% and 80%, 91% and 90%, 72% and 71% in rats receiving the first dose before or after arteries occlusion, respectively). The ischemia-induced sensory-motor impairment was significantly attenuated in rats receiving the first dose of gamma-hydroxybutyrate before arteries occlusion. Finally, the ischemia-induced impairment in spatial learning and memory, evaluated starting 27 days after the ischemic episode, was significantly attenuated by gamma-hydroxybutyrate, either injected first at 30 min before or 10 min after arteries occlusion. Lower doses of gamma-hydroxybutyrate had no significant effect. In conclusion, these results indicate that gamma-hydroxybutyrate provides significant protection against both histological and behavioral consequences of transient global cerebral ischemia in rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844101     DOI: 10.1016/s0014-2999(00)00246-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies.

Authors:  Danielle K Sandsmark; Jonathan E Elliott; Miranda M Lim
Journal:  Sleep       Date:  2017-05-01       Impact factor: 5.849

2.  The Continued Promise of Neuroprotection for Acute Stroke Treatment.

Authors:  Shimin Liu; Steven R Levine
Journal:  J Exp Stroke Transl Med       Date:  2008

3.  Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2010-03-15

4.  Central and peripheral metabolic changes induced by gamma-hydroxybutyrate.

Authors:  Gianina Luca; Julie Vienne; Angélique Vaucher; Sonia Jimenez; Mehdi Tafti
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

Review 5.  Mitochondrial dysfunction induced by nuclear poly(ADP-ribose) polymerase-1: a treatable cause of cell death in stroke.

Authors:  Paul Baxter; Yanting Chen; Yun Xu; Raymond A Swanson
Journal:  Transl Stroke Res       Date:  2013-09-07       Impact factor: 6.829

6.  Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.

Authors:  Vincent P Kelly; Philip J Sherratt; Dorothy H Crouch; John D Hayes
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

7.  Hydroxybutyrate promotes the recovery from cerebral infarction by activating Amp-activated protein kinase signaling.

Authors:  Huisheng Wu; Peipei Guo; Xinyi Li; Zhao Jin; Xin Yang; Yanlin Wang
Journal:  Exp Ther Med       Date:  2018-06-13       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.